Cite
A Phase III trial of polyethylene glycol-conjugated L-asparaginase in patients with multiple myeloma.
MLA
Neeraj R. Agrawal, et al. “A Phase III Trial of Polyethylene Glycol-Conjugated L-Asparaginase in Patients with Multiple Myeloma.” Cancer (0008543X), vol. 98, no. 1, July 2003, pp. 94–99. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=11994909&authtype=sso&custid=ns315887.
APA
Neeraj R. Agrawal, Ronald M. Bukowski, Lisa A. Rybicki, Joanne Kurtzberg, Lewis J. Cohen, & Mohamad A. Hussein. (2003). A Phase III trial of polyethylene glycol-conjugated L-asparaginase in patients with multiple myeloma. Cancer (0008543X), 98(1), 94–99.
Chicago
Neeraj R. Agrawal, Ronald M. Bukowski, Lisa A. Rybicki, Joanne Kurtzberg, Lewis J. Cohen, and Mohamad A. Hussein. 2003. “A Phase III Trial of Polyethylene Glycol-Conjugated L-Asparaginase in Patients with Multiple Myeloma.” Cancer (0008543X) 98 (1): 94–99. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=11994909&authtype=sso&custid=ns315887.